Literature DB >> 27856289

RNA-Binding Protein IGF2BP1 in Cutaneous Squamous Cell Carcinoma.

TaeWon Kim1, Thomas Havighurst2, KyungMann Kim3, Scott J Hebbring4, Zhan Ye4, Juliet Aylward5, Sunduz Keles2, Yaohui G Xu6, Vladimir S Spiegelman7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27856289      PMCID： PMC5326591          DOI： 10.1016/j.jid.2016.10.042

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  14 in total

1.  Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents.

Authors:  Evisabel A Craig; Vladimir S Spiegelman
Journal:  Pigment Cell Melanoma Res       Date:  2011-10-28       Impact factor: 4.693

2.  CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.

Authors:  Felicite K Noubissi; Irina Elcheva; Neehar Bhatia; Abbas Shakoori; Andrei Ougolkov; Jianghuai Liu; Toshinari Minamoto; Jeff Ross; Serge Y Fuchs; Vladimir S Spiegelman
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

3.  Ras gene mutation and amplification in human nonmelanoma skin cancers.

Authors:  W E Pierceall; L H Goldberg; M A Tainsky; T Mukhopadhyay; H N Ananthaswamy
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

4.  Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.

Authors:  Neehar Bhatia; Vladimir S Spiegelman
Journal:  Mol Carcinog       Date:  2005-04       Impact factor: 4.784

5.  Transcriptional Regulation of CRD-BP by c-myc: Implications for c-myc Functions.

Authors:  Felicite K Noubissi; Mikhail A Nikiforov; Nancy Colburn; Vladimir S Spiegelman
Journal:  Genes Cancer       Date:  2010-10

6.  Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.

Authors:  Anokhi Jambusaria-Pahlajani; Peter A Kanetsky; Pritesh S Karia; Wei-Ting Hwang; Joel M Gelfand; Faith M Whalen; Rosalie Elenitsas; Xiaowei Xu; Chrysalyne D Schmults
Journal:  JAMA Dermatol       Date:  2013-04       Impact factor: 10.282

7.  Overexpression of mRNA-binding protein CRD-BP in malignant melanomas.

Authors:  I Elcheva; R S Tarapore; N Bhatia; V S Spiegelman
Journal:  Oncogene       Date:  2008-05-05       Impact factor: 9.867

8.  Mammary tumor induction in transgenic mice expressing an RNA-binding protein.

Authors:  Charles R Tessier; Glenn A Doyle; Brad A Clark; Henry C Pitot; Jeff Ross
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

9.  Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.

Authors:  Kay D Brantsch; Christoph Meisner; Birgitt Schönfisch; Birgit Trilling; Jörg Wehner-Caroli; Martin Röcken; Helmut Breuninger
Journal:  Lancet Oncol       Date:  2008-07-09       Impact factor: 41.316

10.  Role of CRD-BP in the growth of human basal cell carcinoma cells.

Authors:  Felicite K Noubissi; TaeWon Kim; Tisha N Kawahara; William D Aughenbaugh; Eric Berg; B Jack Longley; Mohammad Athar; Vladimir S Spiegelman
Journal:  J Invest Dermatol       Date:  2014-01-27       Impact factor: 8.551
View more
  7 in total

1.  IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer.

Authors:  Sarah F Andres; Kathy N Williams; Jacqueline B Plesset; Jeffrey J Headd; Rei Mizuno; Priya Chatterji; Ashley A Lento; Andres J Klein-Szanto; Rosemarie Mick; Kathryn E Hamilton; Anil K Rustgi
Journal:  Carcinogenesis       Date:  2019-06-10       Impact factor: 4.944

2.  SRC Increases MYC mRNA Expression in Estrogen Receptor-Positive Breast Cancer via mRNA Stabilization and Inhibition of p53 Function.

Authors:  Christopher Abdullah; Hasan Korkaya; Shinji Iizuka; Sara A Courtneidge
Journal:  Mol Cell Biol       Date:  2018-02-27       Impact factor: 4.272

3.  Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling.

Authors:  Jean Christopher Chamcheu; Islam Rady; Roxane-Cherille N Chamcheu; Abu Bakar Siddique; Melissa B Bloch; Sergette Banang Mbeumi; Abiola S Babatunde; Mohammad B Uddin; Felicite K Noubissi; Peter W Jurutka; Yong-Yu Liu; Vladimir S Spiegelman; G Kerr Whitfield; Khalid A El Sayed
Journal:  Int J Mol Sci       Date:  2018-06-16       Impact factor: 5.923

4.  Genetic variant in miR-21 binding sites is associated with colorectal cancer risk.

Authors:  Lisheng Xie; Shuwei Li; Jing Jin; Lei He; Kaili Xu; Lingjun Zhu; Mulong Du; Yanqing Liu; Haiyan Chu; Zhengdong Zhang; Meilin Wang; Danni Shi; Dongying Gu; Min Ni
Journal:  J Cell Mol Med       Date:  2018-12-19       Impact factor: 5.310

5.  Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents.

Authors:  Jason M Biegel; Mayura Dhamdhere; Shuang Gao; Chethana P Gowda; Yuka Imamura Kawasawa; Vladimir S Spiegelman
Journal:  Front Oncol       Date:  2021-03-16       Impact factor: 6.244

Review 6.  The biological function of IGF2BPs and their role in tumorigenesis.

Authors:  Qiu-Ying Du; Zhi-Man Zhu; Dong-Sheng Pei
Journal:  Invest New Drugs       Date:  2021-07-12       Impact factor: 3.850

7.  Long Noncoding RNA DCST1-AS1 Promotes Cell Proliferation and Metastasis in Triple-negative Breast Cancer by Forming a Positive Regulatory Loop with miR-873-5p and MYC.

Authors:  Li Tang; Yuli Chen; Xun Tang; Da Wei; Xinyu Xu; Feng Yan
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.